Phenotypes and concentration of PON1 in cardiovascular disease: The role of nutrient intake

Nutr Metab Cardiovasc Dis. 2020 Jan 3;30(1):40-48. doi: 10.1016/j.numecd.2019.08.013. Epub 2019 Sep 10.

Abstract

Background and aims: Paraoxonase 1 (PON1) is considered to play a crucial role as an anti-atherosclerotic factor. The PON1 activity is affected by genetic polymorphisms, environmental factors, age, sex, lifestyle, pharmaceutical drugs, and dietary factors. The aim of this study was to evaluate the association between macro- and micronutrients as well as PON1 concentration and activities in patients with cardiovascular diseases (CVD), cardiovascular risk factors but no CVD (CRF), and in healthy controls (control group).

Methods and results: A case-control study was carried out with 356 volunteers from the Mexican Institute of Social Security, Mexico. Clinical parameters, lipid profile, PON1 activities (AREase, LACase, CMPAase and PONase), and PON1 concentration were evaluated. There was a differential intake of macro- and micronutrients among the study groups. The intake of proteins and carbohydrates was higher in the CVD group than in the CFR and control groups (p < 0.05). AREase, LACase, and CMPAase activities and PON1 concentration were lowest in the CVD group.

Conclusion: LACase and CMPAase activities, as well as PON1 concentration, could be included in the battery of CVD predictive biomarkers in the Mexican population.

Keywords: Cardiovascular diseases; Diet; PON1 concentration; Paraoxonase 1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aryldialkylphosphatase / blood*
  • Biomarkers / blood
  • Cardiovascular Diseases / blood*
  • Cardiovascular Diseases / diagnosis
  • Cardiovascular Diseases / epidemiology
  • Cardiovascular Diseases / physiopathology
  • Case-Control Studies
  • Diet* / adverse effects
  • Dietary Carbohydrates / administration & dosage
  • Dietary Fats / administration & dosage
  • Dietary Proteins / administration & dosage
  • Energy Intake
  • Female
  • Humans
  • Male
  • Mexico / epidemiology
  • Micronutrients / administration & dosage
  • Middle Aged
  • Nutritional Status*
  • Nutritive Value*
  • Phenotype
  • Prognosis
  • Protective Factors
  • Risk Factors

Substances

  • Biomarkers
  • Dietary Carbohydrates
  • Dietary Fats
  • Dietary Proteins
  • Micronutrients
  • Aryldialkylphosphatase
  • PON1 protein, human